FDA 483 - Deerland Enzymes dba Deerland Probiotics and Enzymes Inc. - December 19, 2024

Deerland Enzymes dba Deerland Probiotics and Enzymes Inc. in Kennesaw, GA, a dietary supplement contract manufacturer, received a Form 483 with five observations. The inspection revealed significant issues with master manufacturing records, including a lack of specifications for ingredients, endotoxin testing, and pesticide testing for incoming materials. Additionally, the firm failed to verify the identity of a dietary ingredient, used unsuitable equipment, and had deficiencies in quality control review of monitoring records.